We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Ocular pain

News List

IACTA Pharmaceuticals and Pharmaleads to Develop the World's First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain prnasia
January 08, 2021
IACTA Pharmaceuticals, Inc. and Pharmaleads, with Pharmaleads Greater China, today announced they have entered into licensing agreements, with IACTA acquiring global rights to Pharmaleads' Dual Enkephalinase Inhibitors (DENKI®), a novel class of ...
FDA Approves Dextenza drugs
December 04, 2018
FDA Approves Dextenza (dexamethasone ophthalmic insert) for the Treatment of Ocular Pain Following Ophthalmic Surgery.Ocular Therapeutix™, Inc. a biopharmaceutical company focused .......
Ocular Therapeutix resubmits Dextenza to FDA seeking approval for post-surgical ocular pain firstwordpharma
January 24, 2017
Ocular Therapeutix on Monday said it resubmitted Dextenza (dexamethasone) to the FDA seeking approval for the treatment of ocular pain occurring after ophthalmic surgery.